Vol 27, No 1 (2023)
Original paper
Published online: 2023-02-09

open access

Page views 2367
Article views/downloads 387
Get Citation

Connect on Social Media

Connect on Social Media

Original paper

Hypertension phenotypes in rural part of East Indonesia: the TENSI pilot study

Aryandhito Widhi Nugroho1Nur Upik En Masrika2
1Department of Surgery, Faculty of Medicine, Khairun University, Gambesi, Ternate, Indonesia
2Department of Biomedics, Faculty of Medicine, Khairun University, Gambesi, Ternate, Indonesia

Address for correspondence: Aryandhito Widhi Nugroho, MD, PhD, Department of Surgery, Khairun University, Indonesia, tel: (+62) 813 898 595 09; e-mail: aryandhitowidhinugroho@gmail.com

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially

Abstract
Background: Though extensively studied in other Asian countries, office and home blood pressure (BP)-based hypertension determination and phenotypes in rural population are still scarcely investigated in Indonesia. We aim to elaborate this in an East Indonesia rural area, by implementing two available BP thresholds.
Material and methods: The Ternate Sehat Indonesia (TENSI) pilot study obtained demographic, anthropometric, biochemistry, office and home BP data from 146 residents aged18 years old living in Ternate Island from July–August 2022. Hypertension and its phenotypes were defined in accordance with the 2019 Indonesian Society of Hypertension (InaSH) and the 2017 American College of Cardiology/American Heart Association (ACC/AHA) BP guidelines. Office and home BP differences were analyzed within each participant’s characteristics.
Results: Mean mm Hg ± SD office and home (i) systolic BP were 121.8 ± 17.9 and 117.8 ± 14.8 mm Hg (p < 0.001), (ii) diastolic BP were 77.9 ± 12.1 and 74.7 ± 8.9 mm Hg (p < 0.001). Hypertension was evident in 26% (InaSH) and 34.2% (ACC/AHA) participants. Moreover, 17.4% (InaSH) and 24.8% (ACC/AHA) of those self-reported to not having hypertension were found to be hypertensives. The proportion of sustained, white-coat, and masked hypertension were 7.5%, 9.6%, 8.9% (InaSH), and 8.2%, 21.2%, 4.8% (ACC/AHA). Compared to office BP, home BP significantly differed throughout more characteristics.
Conclusions: Our study has ascertained the actual hypertension status and phenotypes within a rural East Indonesia environment. The revelation of stronger home BP ability to detect BP differences may promote its application within the population in the future.
Key words: blood pressure; office; home; hypertension; phenotypes
Arterial Hypertens. 2023, vol. 27, no. 1, pages: 36–45
DOI: 10.5603/AH.a2023.0007

Introduction

Hypertension is a commonly known major risk factor for cardiovascular disease, a dreadful scourge responsible for many preventable mortality and morbidity worldwide [1]. Almost a third of global adult residents are hypertensives [2]. Despite advancement in blood pressure (BP) monitoring technology and ubiquitous distribution of antihypertensives, low and middle income Asian countries continue to exhibit worrisome prospect of increased prevalence of hypertension [3]. Indonesia, a developing, low-to-middle income country in South East Asia, is one populous nation that contributes greatly to the global burden of hypertension due to low treatment rate (less than 25% and 20% for women and men, respectively) as well as low control rate (5%) [4, 5]. With the latest national hypertension prevalence being 34.1% in 2018, early detection and management is of utmost importance for epidemic control, particularly in rural area, where hypertension is more prevalent than in its urban counterpart [6, 7]. Since discovered to have stronger mortality predictive value than office BP (OBP) in the Ohasama study [8], home blood pressure (HBP) measurement has been widely applied and included in the guidelines for hypertension management in major Asian countries [9–12]. Furthermore, the identification of important hypertension phenotypes, e.g., masked (normal OBP with elevated HBP), white-coat- (elevated OBP with normal HBP), and sustained hypertension (elevated OBP and HBP), all increase the risk of cardiovascular event and/or death, have been made possible with HBP measurement [13–16]. Unfortunately, albeit the existence of a generous body of literature on HBP measurement and hypertension phenotypes among urban and rural Asian population [17–19], analogous effort on rural Indonesian population is scarce [12–20]. We aim to investigate the measured hypertension status through OBP and HBP measurement, implementing the currently used 2019 Indonesian Society of Hypertension threshold (InaSH) and the 2017 American College of Cardiology/American Heart Association (ACC/AHA) BP threshold [21, 22, 25], and to examine the presence and attributes of masked, white-coat, and sustained hypertension among residents living in a remote island in North Maluku, Indonesia.

Material and methods

Study design

The Ternate Sehat Indonesia (TENSI, or Healthy Ternate Indonesia) is a pilot public health effort focusing on the identification of risk factors for elevated BP in Ternate, an island populated by 205,870 inhabitants in North Maluku, East Indonesia [23]. Kalumata Primary Health Care Center, the health care facility with the largest area coverage (36.3%), was selected as the initial site. Invitation to study participation was broadcasted through local radio station and public posters one month prior to commencement. Willing participants were counseled on research protocol. Residents aged18 years old, not pregnant, and able to provide written consents were included in the study. The study was conducted in accordance with the Declaration of Helsinki Ethical Principles and Good Clinical Practices. Finally, the Institutional Review Board of Khairun University, Ternate, approved the study protocol.

Office-based data collection

Information on age, sex, length of education, self-reported history of hypertension and diabetes, smoking status, waist circumference (WC), waist-to-hip ratio (WHR), body mass index (BMI), and fasting plasma glucose (FPG) were obtained as apprised by standardized WHO STEPwise Approach to Chronic Disease Risk Factor Surveillance (STEPS) Instrument [24]. Local languages were used in communicating with non-Indonesian speaking indigenous people. Age was categorized as young adult (< 44 years old) and middle-aged to elderly (≥ 44 years old). Hypertension and diabetes history were based on the participants’ personal recall of previous diagnoses and/or current medication status. Smoking was dichotomized as current and never/past smokers. OBP was measured in conformity with the 2019 InaSH consensus, using the Indonesian Ministry of Health-approved oscillometric BP device (Sinocare BA-801; AKL 20051124995; Sinocare Healthcare Indonesia) [25]. The final OBP value was the average of two measurements. WC was measured at the level between the lower ribs and the iliac crest. WHR was defined as WC divided by hip circumference, measured by the largest part of the gluteal area. BMI, calculated as body weight in kilogram divided by height in meter squared, was categorized as overweight/obese (≥ 23) and normal/underweight (< 23), in line with the WHO BMI cut-off point for Asian population [26].

Home-based data collection

Using identical device, participants were instructed to self-measure their HBP in accordance with the 2019 InaSH consensus [25]. Two morning BP (1-minute interval between readings) were measured in sitting position after 2 minutes of rest, within 1 hour after waking up, after urination, prior to dosing and breakfast, while two evening BP (1-minute interval between readings) were measured before retiring, in sitting position after 2 minutes of rest, for four days. All values were recorded in a provided diary, and the averages of these were taken as the final HBP value. Daily morning-and-evening reminders were made by the research investigators in regular time unique to each participant’s schedule to ensure BP measurement compliance. FPG serum (mg/dL) was measured once after an 8-hours no calorie intake overnight, using the Indonesian Ministry of Health-approved glucometer device (Sinocare Safe-Accu 2; AKL 20101027017; Sinocare Healthcare Indonesia).

Hypertension and its phenotypes definition

Most BP guidelines established in Asian countries, e.g., Japan, Korea, and China, define adult hypertension as (i) office systolic BP (SBP)140 mm Hg and/or diastolic BP (DBP)90 mm Hg, or (ii) home SBP135 mm Hg and/or DBP85 mm Hg [10–12, 21]. Subsequent to the introduction of the 2017 ACC/AHA guideline, the following cut-off values were introduced: office/home SBP130 mm Hg and/or DBP80 mm Hg [9, 22]. Whilst Indonesia adopted the former threshold as its national BP guideline, the authors decided to define hypertension in this study according to both thresholds since no Indonesian clinical trials were included in their development.

Vis-à-vis with the aforementioned scientific differences, (i) white-coat hypertension is defined as office SBP140 mm Hg and/or DBP90 mm Hg, with home SBP < 135 mm Hg and DBP < 85 mm Hg (InaSH), or office SBP130 mm Hg and/or DBP80 mm Hg, with home SBP < 130 mm Hg and DBP < 80 mm Hg (ACC/AHA), (ii) masked hypertension is defined as office SBP <140 mm Hg and DBP <90 mmHg, with home SBP135 mm Hg and/or DBP85 mm Hg (InaSH), or office SBP < 130 mm Hg and DBP < 80 mm Hg, with home SBP130 mm Hg and/or DBP80 mm Hg (ACC/AHA) (iii) sustained hypertension is defined as office SBP140 mm Hg and/or DBP90 mm Hg, with home SBP135 mm Hg and/or DBP85 mm Hg (InaSH), or office SBP130 mm Hg and/or DBP80 mm Hg, with home SBP130 mm Hg and/or DBP80 mm Hg (ACC/AHA) [22, 25].

Statistical analyses

Continuous variables were presented as mean + standard deviation or median (interquartile range), and categorical variables as n (proportion) as suitable. Group differences in mean or median were tested using Student’s t- or Mann-Whitney U-test (2 groups) and one way-analysis of variance or Kruskal-Wallis tests (> 2 groups), and in proportions using X2 or Fisher’s Exact test. Post hoc analysis between groups was performed by Tukey or Bonferroni tests, as appropriate. All analyses were carried out using SPSS Version 25 software (IBM SPSS). A two-tailed p-value of < 0.05 is accounted as statistically significant.

Results

From July to August 2022, a total of 165 participants were registered. After excluding those who were pregnant (n = 9) and presented inadequate home BP data (n = 10), 146 participants (88.5%) were finally included into the study.

Basic characteristics of the study subjects

Table 1 presents the basic characteristics of the study subjects and measured hypertension status by self-reported hypertension history. Compared to patients without known hypertension, those with self-reported hypertension history were significantly older, more of male dominance, less educated, more diabetic, exhibited larger WC, bigger WHR, displayed higher FPG and more elevated office and home SBP and DBP. Simultaneous OBP and HBP measurement revealed 68% and 80% participants in the hypertension history group, and 17.4% and 24.8% in the non-hypertension history group, to be actually hypertensive, as per the InaSH and ACC/AHA guidelines, respectively.

Table 1. Basic characteristics and actual hypertension prevalence of the study population by hypertension history (n = 146)

Variables

All

(n = 146)

HT history

(n = 25)

No HT history

(n = 121)

p

Demographics

Age (years)

34.9 ± 15.9

51.2 ± 14.6

31.5 ± 14

< 0.001

Female, n (%)

106 (72.6)

14 (56)

92 (76)

0.04

Education (years)

12.1 ± 3

10.9 ± 3.6

12.3 ± 2.8

0.03

Risk factors

Smoking, n (%)

27 (18.5)

4 (16)

23 (19)

0.99

Diabetes, n (%)

17 (11.6)

7 (28)

10 (8.3)

0.01

Anthropometric indices

Waist circumference [cm]

85.2 ± 13

93.7 ± 12.8

83.4 ± 12.4

< 0.001

Waist-to-hip ratio

0.9 ± 0.1

0.9 ± 0.1

0.8 ± 0.1

0.01

Body mass index

25.4 ± 5.4

27 ± 4.8

25 ± 5.4

0.09

FPG [mg/dL]

102.2 ± 43.3

119.7 ± 53.4

98.8 ± 40.5

0.04

Systolic blood pressure [mm Hg]

Office

121.8 ± 17.9

141 ± 22.4

117.8 ± 13.9

< 0.001

Home

117.8 ± 14.8

135.1 ± 15.8

114.2 ± 11.8

< 0.001

Diastolic blood pressure [mm Hg]

Office

77.9 ± 12.1

90.8 ± 15.2

75.2 ± 9.6

0.001

Home

74.7 ± 8.9

82.6 ± 11.8

73 ± 7.3

< 0.001

Actual HT prevalence, n (%)

InaSH, n (%)

38 (26)

17 (68)

21 (17.4)

< 0.001

ACC/AHA, n (%)

50 (34.2)

20 (80)

30 (24.8)

< 0.001

Office and home SBP and DBP differences within groups of variables

Table 2 shows the office and home SBP differences in each variable. Compared to their counterparts, office SBPs were significantly more elevated in those aged44 years old, with self-reported hypertension history, BMI23 and FPG > 100 mg/dL. These are further augmented by home SBPs, which apart from having the aforementioned findings, were also significantly higher in male, less educated, and with self-proclaimed diabetes history. Similar pattern were observed in DBP, with lesser statistical significance of difference displayed by the sex group in home DBP (Tab. 3).

Table 2. Office and home systolic blood pressure (SBP) differences within each characteristics

Variables

Group

Office SBP [mm Hg]

Home SBP [mm Hg]

Mean ± SD

p

Mean ± SD

p

Sex

Female

120.4 ± 17.3

0.13

115.7 ± 14.3

0.01

Male

125.5 ± 19

123.3 ± 14.7

Age

<44

117.7 ± 13.7

< 0.001

113.5 ± 11.2

< 0.001

>44

131.1 ± 22.4

127.3 ± 17.4

Education years

<12

122.9 ± 19

0.2

119.8 ± 15.6

0.001

>12

118.7 ± 14.3

112.3 ± 10.6

Smoking status

Yes

122.1 ± 14

0.9

120.9 ± 13.6

0.20

No

121.7 ± 18.7

117 ± 15

HT history

Yes

141 ± 22.4

< 0.001

135.1 ± 15.8

< 0.001

No

117.8 ± 13.9

114.2 ± 11.8

DM history

Yes

126.7 ± 20.3

0.2

124.9 ± 15.5

0.03

No

121.2 ± 17.5

116.8 ± 14.5

Waist circumference

< 85

115.1 ± 13

< 0.001

111.2 ± 10.2

< 0.001

≥85

128 ± 19.5

123.8 ± 15.9

Body mass index

< 23

114 ± 10.9

< 0.001

110.7 ± 10.1

<0.001

≥ 23

126.1± 19.5

121.7 ± 15.6

Waist-to-hip ratio

< 0.9

118.1 ± 14.9

0.01

112.7 ± 10.4

< 0.001

≥ 0.9

126.3 ± 20.1

123.9 ± 17

FPG

≤ 100

120 ± 15.2

0.03

115.8 ± 13.3

0.02

> 100

127.5 ± 22.5

123.2 ± 16.9

Table 3. Office and home diastolic blood pressure (DBP) differences within each characteristics

Variables

Group

Office DBP [mm Hg]

Home DBP [mm Hg]

Mean ± SD

p

Mean ± SD

p

Sex

Female

77.3 ± 11.5

0.37

73.9 ± 7.8

0.08

Male

79.4 ± 14

76.8 ± 11.2

Age

< 44

75.9 ± 10.5

0.009

72.9 ± 7.1

0.003

≥ 44

82.3 ± 14.6

78.6 ± 11.1

Education years

≤ 12

78.7 ± 12.6

0.15

76 ± 9.2

0.002

> 12

75.5 ± 11

71 ± 7.1

Smoking status

Yes

78.9 ± 12.2

0.64

78.7 ± 12

0.06

No

77.6 ± 12.3

73.8 ± 7.9

HT history

Yes

90.8 ± 15.2

< 0.001

82.6 ± 11.8

< 0.001

No

75.2 ± 9.6

73 ± 7.3

DM history

Yes

81.1 ± 13

0.25

81 ± 10.9

0.002

No

77.4 ± 12.1

73.8 ± 8.3

Waist circumference

< 85

74.4 ± 9.5

0.001

72 ± 7

< 0.001

≥ 85

81 ± 13.5

77.2 ± 9.8

Body mass index

< 23

73.3 ± 8.6

< 0.001

70.9 ± 6.9

< 0.001

≥ 23

80.4 ± 13.2

76.7 ± 9.3

Waist-to-hip ratio

< 0.9

76.2 ± 10.7

0.08

72.8 ± 7.6

0.004

≥ 0.9

79.8 ± 13.7

77 ± 9.9

FPG

≤ 100

76.5 ± 10.8

0.009

73.1 ± 8.4

< 0.001

> 100

82.7 ± 15.3

79.1 ± 8.3

Proportion and characteristics of each hypertension phenotypes

The proportion of normal office SBPs were 87.7% (InaSH) and 72.6% (ACC/AHA), while that of normal home BPs were 89.7% (InaSH) and 87% (ACC/AHA). Figure 1 demonstrates the SBP-based distribution of sustained, white-coat and masked hypertension of study subjects as follows: 6.2%, 6.2%, 4.1% (InaSH) and 8.2%, 19.2%, 4.8% (ACC/AHA). When considering both SBP and DBP, these proportions, as in order previously stated, change into 7.5%, 9.6%, 8.9% (InaSH), and 8.2%, 21.2%, 4.8% (ACC/AHA).

52369.png
Figure 1. The distribution of hypertension phenotypes status based on office and home systolic blood pressure, categorized according to 2019 Indonesian Society of Hypertension (InASH) and American College of Cardiology/American Heart Association/Heart Rhythm Society (ACC/AHA) guidelines

The characteristic differences across hypertension phenotypes based on the InaSH guideline are presented in Table 4. As opposed to the normotensive, the sustained and masked hypertension groups were significantly older, more of male dominance, less educated, more diabetic, larger WC, WHR, BMI and FPG. Quasi-analogous pattern was identified within hypertension phenotypes based on the ACC/AHA threshold (Tab. 5).

Table 4. Characteristic differences across hypertension subgroups based on the InaSH guideline

Variables

Normotension (n = 108)

White-coat HT

(n = 14)

Masked HT

(n = 13)

Sustained HT

(n = 11)

p

Demographics

Age (years)

30.1 ± 13.3

42.6 ± 14.8*

49.6 ± 12.8*

54.5 ± 15.5*

< 0.001

Female, n (%)

82 (78.4)

12 (85.7)

7 (53.8)*

5 (45.5)*

0.05

Education (years)

12.6 ± 2.7

11.5 ± 3

±

10.3 ± 14.3*

0.001

Risk factors

Smoking, n (%)

16 (14.8)

3 (21.4)

6 (46.2)*

2 (18.2)

0.05

Self-reported HT, n (%)

8 (7.4)

5 (35.7)*,†

3 (23.1)*,**

9 (81.8)*,**,†

< 0.001

Self-reported DM, n (%)

10 (9.3)

0 (0)*

4 (30.8)*

3 (27.3)*

0.02

Anthropometric indices

WC (cm)

82.5 ± 12

89.3 ± 11.7

92.5 ± 15.2*

97.3 ± 11.5*

< 0.001

WHR

0.8 ± 0.1

0.8 ± 0.1**,†

0.9 ± 0.1*,**

1 ± 0.1*,**

< 0.001

BMI

24.4 ± 5.2

26.8 ± 4.2

28.6 ± 4.9*

29.6 ± 5.4*

0.001

FPG >100 mg/dL

17 (17)

4 (28.6)*

8 (66.7)*,**

6 (58)*,**,†

< 0.001

Systolic blood pressure [mm Hg]

Office

114.9 ± 11.5

140 ± 11*,†

126.4 ± 6.2*,**

160.5 ± 18.9*,**,†

< 0.001

Home

112.1 ± 9.2

121.8 ± 6.2*

134.1± + 13.6*,**

149.3 ± 14.2*,**

< 0.001

Diastolic blood pressure [mm Hg]

Office

73.3 ± 8.2

90.8 ± 7.4*,†

80.8 ± 4.7**

103.3 ± 12.4*,**,†

< 0.001

Home

71.5 ±+ 6

77.9 ± 5.5*

83.3 ± 5.8

91.1 ± 13.4*,**,†

< 0.001

Table 5. Characteristics differences across hypertension phenotypes based on the American College of Cardiology/American Heart Association/Heart Rhythm Society (ACC/AHA) guidelines

Variables

Normotension

(n = 96)

White-coat HT

(n = 31)

Masked HT

(n = 7)

Sustained HT

(n = 12)

p

Demographics

Age (years)

29.6 ± 12.3

37 ± 14.1*,†

61.7 ± 13.7*,#

55.4 ± 14*,#

< 0.001

Female, n (%)

73 (76)

24 (77.4)

4 (57.1) *,#

5 (41.7) *,#

0.05

Education (years)

12.3 ± 2.7

12.6 ± 3.2

10.1 ± 2.3*

10.2 ± 4.1*

0.03

Risk factors

Smoking, n (%)

15 (15.6)

7 (22.6)

2 (28.6)

3 (25)

0.5

Self-reported HT, n (%)

5 (5.2)

7 (22.6) *,†

3 (42.9) *,#

10 (83.3)*,#,†

< 0.001

Self-reported DM, n (%)

8 (8.3)

4 (12.9)

2 (28.6)

3 (25)

0.09

Anthropometric indices

WC [cm]

81.7 ± 12.4

89.2 ± 11.2*

94.3 ± 11*

97.4 ± 11*

< 0.001

WHR

0.88 ± 0.08

0.88 ± 0.06

0.96 ± 0.05*,#

0.96 ± 0.06*,#

< 0.001

BMI

24.2 ± 5.4

27.2 ± 4.8*

27.3 ± 3.3

29.1 ± 4.7*

0.002

FPG >100 mg/dL

17 (22.9)

9 (31) *

4 (42.9)*

5 (54.5)*

0.03

Systolic blood pressure [mm Hg]

Office

112.1 ± 9.4

136.1 ± 7.9

124.9 ± 3.2

159.6 ± 18.2*,#,†

< 0.001

Home

111.3 ± 9

120.6 ± 6.2

142 ± 14.4*,#

148.3 ± 13.8*,#

< 0.001

Diastolic blood pressure [mm Hg]

Office

72.5 ± 7.9

85.9 ± 8.3*,†

74.8 ± 5.9#,†

101.4 ± 13.4*,#,†

< 0.001

Home

71.9 ± 6.9

76.8 ± 6.4*

76.4 ± 5.3

90.3 ± 13.1*,#,†

< 0.001

Discussion

The TENSI study was a pilot effort to determine the measured hypertension status and phenotypes, based on two available BP guidelines, in Ternate Island through the application of OBP and HBP measurements. Interestingly, among participants who self-reported to not having any hypertension history, 17.4% (InaSH) and 24.8% (ACC/AHA) were actually hypertensives. These “concealed” hypertensives were further found to be evident in each phenotype: 64.3%, 76.9%, 18.2% (InaSH) and 77.4%, 57.1%, 16.7% (ACC/AHA) within the white-coat, masked, and sustained hypertension groups, respectively. This discrepancy between self-reported and measured hypertension status, as elaborated by Sohn and Gonçalves et al., could be explained by disparities in regional, socioeconomic, religious, and cultural perspectives [27, 28], warranting a more rigorous BP monitoring, health education, and evaluation of related risk factors in general population.

In each study variables, OBP and, to a stronger degree, HBP value were significantly higher in participants who were middle aged-to elderly, male, less educated, with self-reported hypertension and diabetes history, higher WC, BMI, WHR, and FPG. Synchronous results were presented by these preceding studies: Kawabe et al., Wang et al., and Cacciolati et al. previously confirmed the higher prevalence of masked hypertension in older and male subjects in Japan, US, and France, respectively [29–31]. Educational factor, e.g., years of schooling and academic degrees attained, were proven by Liu et al. and Sun et al. to be inversely associated with BP [32, 33], most likely related to personal awareness and healthy lifestyle [34]. Diabetes and insulin resistance, through means of recently uncovered mechanisms involving renin-angiotensin-aldosterone system, sympathetic nervous system, cellular processes and gut microbiota, increase the risk of developing hypertension [35]. Asayama et al. found a direct relationship between WC and BMI with incidence of masked and white-coat hypertension [36]. Ahn et al., Kuwabara et al, and Lv et al. discovered a strong independent association of higher FPG with incidence of hypertension [37–39]. In comparison with OBP, as ascertained by Horikawa et al. and Kadowaki et al., HBP exhibited better ability to detect SBP and DBP differences within groups of variables, further emphasizes its role in BP monitoring [40, 41].

Regarding hypertension phenotypes in Indonesia, Turana et al. in the AsiaBP@Home study article reported the following prevalence of white-coat, masked, and sustained hypertension groups: 13%, 9%, 54% (InaSH) and 16%, 3%, 71% (ACC/AHA) [12]. The authors were aware that this prevalence incompatibility might be mainly caused by discrepancies in the study subjects characteristics, where ours consisted of residents in a rural archipelagic area, with peculiar anthropometric, sociocultural, and lifestyle compared to urban people.

Over the last ten years, a number of internationally published hypertension studies on rural Indonesia population were conducted [20, 37–39]. Hussain et al reported a hypertension prevalence of 46.4% among 4,881 rural populations aged40 years old recruited from 99 villages in seven East Indonesia provinces [20]. Rahmawati et al. identified a direct relationship between hypertension knowledge and medication adherence in 384 hypertensives participants aged45 years old originated from eight villages in Yogyakarta, West Indonesia [42]. Astutik et al. described a hypertension prevalence of 27.8% among 54 women aged45 years old living in a rural East Java village, West Indonesia [43]. Widyaningsih et al. reported on missed opportunities in hypertension risk factors screening from 31,554 rural residents aged15 years old residing in North Sumatra, East Java, and Central Java provinces, West Indonesia [44]. Our study offered an additional novel perspective on measured hypertension status and its phenotypes in rural Indonesia through the utilization of self-HBP measurement by study participants.

Study limitations

Several issues were identified that would potentially compromise the result interpretation. The study concentrated on rural residents of Ternate Island, who bore distinct features compared to those living in other areas in Indonesia and overseas. Having small number of participants, the authors believe that incorporating more health care center and residents would improve representativeness. The recruitment of participants via media advertisements inevitably introduced selection bias, an issue which needs to be addressed by random selection in future studies. Regarding BP device, though officially licensed by the National Health Ministry, Sinocare BA-801 has not yet been validated for international use [45]. This is largely due to limited funding, precluding procurement of internationally approved BP device and reducing data collection period.

Conclusion

This study presented the actual hypertension status of Ternate Island’s rural residents, determined by OBP and HBP measurement. By implementing two currently existing BP thresholds, the existence of “concealed” hypertensives and the prevalence of hypertension phenotypes were described. Limited budget, manpower, and sociocultural challenges are but few obstacles in the effort to prevent the increase of hypertension in rural area. Nonetheless, proceeding from this study, the authors aim to build joint actions with stakeholders and fellow researchers in hypertension for a more comprehensive study in the future.

Acknowledgment

The authors would like to thank Amalia Sumayah Ammarie, Khairunnisa Azzahra, Muhammad Fauzan Iftihar, Mutmainah Dj Mandar, Nazla Fajriyah Albaar, Novriyani Tahmid, Rochmat Nurhidayat, Septiana Waraningsih, Widya Ayuning Paramitha, and Yusril Rafiqzal Zuldan for their contributions in the study data collection, as well as Khatimah Albaar as the head of Kalumata Primary Health Care Facility.

Conflict of interest

All authors declare no conflict of interest.

Funding

This study was supported by scientific grant from Khairun University, Ternate, Indonesia (No. 660/PEN-PKUPT/PL/2022).

References

  1. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159): 1736–1788, doi: 10.1016/S0140-6736(18)32203-7, indexed in Pubmed: 30496103.
  2. Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016; 134(6): 441–450, doi: 10.1161/CIRCULATIONAHA.115.018912, indexed in Pubmed: 27502908.
  3. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020; 16(4): 223–237, doi: 10.1038/s41581-019-0244-2, indexed in Pubmed: 32024986.
  4. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304): 957–980, doi: 10.1016/S0140-6736(21)01330-1, indexed in Pubmed: 34450083.
  5. Nguyen T, Chow C. Global and national high blood pressure burden and control. Lancet. 2021; 398(10304): 932–933, doi: 10.1016/s0140-6736(21)01688-3, indexed in Pubmed: 34450082.
  6. Ministry of Health and National Institute of Health Research and Development. National report on basic health research (RISKESDAS). Ministry of Health, Jakarta 2018.
  7. Chow CK, Teo KK, Rangarajan S, et al. PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310(9): 959–968, doi: 10.1001/jama.2013.184182, indexed in Pubmed: 24002282.
  8. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998; 16(7): 971–975, doi: 10.1097/00004872-199816070-00010, indexed in Pubmed: 9794737.
  9. Wang TD, Chiang CE, Chao TH, et al. 2022 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. Acta Cardiol Sin. 2022; 38(3): 225–325, doi: 10.6515/ACS.202205_38(3).20220321A, indexed in Pubmed: 35673334 .
  10. Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019; 42(9): 1235–1481, doi: 10.1038/s41440-019-0284-9, indexed in Pubmed: 31375757.
  11. Liu J. Highlights of the 2018 Chinese hypertension guidelines. Clin Hypertens. 2020; 26: 8, doi: 10.1186/s40885-020-00141-3, indexed in Pubmed: 32377372.
  12. Turana Y, Tengkawan J, Soenarta AA. Asian management of hypertension: Current status, home blood pressure, and specific concerns in Indonesia. J Clin Hypertens (Greenwich). 2020; 22(3): 483–485, doi: 10.1111/jch.13681, indexed in Pubmed: 31680397.
  13. Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006; 47(5): 846–853, doi: 10.1161/01.HYP.0000215363.69793.bb, indexed in Pubmed: 16567588.
  14. Mancia G, Bombelli M, Cuspidi C, et al. Cardiovascular Risk Associated With White-Coat Hypertension: Pro Side of the Argument. Hypertension. 2017; 70(4): 668–675, doi: 10.1161/HYPERTENSIONAHA.117.08903, indexed in Pubmed: 28847891.
  15. Fujiwara T, Yano Y, Hoshide S, et al. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population. JAMA Cardiol. 2018; 3(7): 583–590, doi: 10.1001/jamacardio.2018.1233, indexed in Pubmed: 29800067.
  16. Palla M, Saber H, Konda S, et al. Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis. Integr Blood Press Control. 2018; 11: 11–24, doi: 10.2147/IBPC.S128947, indexed in Pubmed: 29379316.
  17. Weber MA, Lackland DT. Hypertension in Asia 2021: A major contribution to worldwide understanding and management of hypertension. J Clin Hypertens (Greenwich). 2021; 23(3): 403–405, doi: 10.1111/jch.14172, indexed in Pubmed: 33455048.
  18. Chia YC, Buranakitjaroen P, Chen CH, et al. HOPE Asia Network. Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia Network. J Clin Hypertens (Greenwich). 2017; 19(11): 1192–1201, doi: 10.1111/jch.13058, indexed in Pubmed: 28815840.
  19. Turana Y, Tengkawan J, Chia YC, et al. HOPE Asia Network. Hypertension and stroke in Asia: A comprehensive review from HOPE Asia. J Clin Hypertens (Greenwich). 2021; 23(3): 513–521, doi: 10.1111/jch.14099, indexed in Pubmed: 33190399.
  20. Hussain MA, Mamun AAl, Reid C, et al. Prevalence, Awareness, Treatment and Control of Hypertension in Indonesian Adults Aged ≥40 Years: Findings from the Indonesia Family Life Survey (IFLS). PLoS One. 2016; 11(8): e0160922, doi: 10.1371/journal.pone.0160922, indexed in Pubmed: 27556532.
  21. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. J Hypertens. 2018; 36(10): 1953–2041, doi: 10.1097/hjh.0000000000001940, indexed in Pubmed: 30234752.
  22. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018; 138(17): e426–e83, doi: 10.1161/CIR.0000000000000597, indexed in Pubmed: 30354655 .
  23. Central Bureau of Statistics. The North Maluku Central Bureau of Statistics. Central Bureau of Statistics, Ternate 2021.
  24. World Health Organization. WHO STEPS surveillance manual: the WHO STEPwise approach to chronic disease risk factor surveillance. WHO non-communicable diseases and mental health cluster, Geneva 2005.
  25. The Indonesian Society of Hypertension.. Treatment of hypertension consensus. Indonesian Society of Hypertension, Jakarta 2019.
  26. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403): 157–163, doi: 10.1016/S0140-6736(03)15268-3, indexed in Pubmed: 14726171.
  27. Gonçalves VSS, Andrade KRC, Carvalho KMB, et al. Accuracy of self-reported hypertension: a systematic review and meta-analysis. J Hypertens. 2018; 36(5): 970–978, doi: 10.1097/HJH.0000000000001648, indexed in Pubmed: 29232280.
  28. Sohn K. Sick But Unaware: Hypertension in Indonesia. Biodemography Soc Biol. 2015; 61(3): 298–318, doi: 10.1080/19485565.2015.1091719, indexed in Pubmed: 26652684.
  29. Kawabe H, Saito I. Influence of age and sex on prevalence of masked hypertension determined from home blood pressure measurements. J Hum Hypertens. 2007; 21(1): 94–95, doi: 10.1038/sj.jhh.1002108, indexed in Pubmed: 17082798.
  30. Wang YC, Shimbo D, Muntner P, et al. Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure. Am J Epidemiol. 2017; 185(3): 194–202, doi: 10.1093/aje/kww237, indexed in Pubmed: 28100465.
  31. Cacciolati C, Tzourio C, Hanon O. Blood pressure variability in elderly persons with white-coat and masked hypertension compared to those with normotension and sustained hypertension. Am J Hypertens. 2013; 26(3): 367–372, doi: 10.1093/ajh/hps054, indexed in Pubmed: 23382487.
  32. Liu SY, Buka SL, Linkletter CD, et al. The association between blood pressure and years of schooling versus educational credentials: test of the sheepskin effect. Ann Epidemiol. 2011; 21(2): 128–138, doi: 10.1016/j.annepidem.2010.11.004, indexed in Pubmed: 21184953.
  33. Sun K, Lin D, Li M, et al. Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adults. J Epidemiol Community Health. 2022 [Epub ahead of print]; 76(5): 451–457, doi: 10.1136/jech-2021-217006, indexed in Pubmed: 34996807.
  34. Tedesco MA, Di Salvo G, Caputo S, et al. Educational level and hypertension: how socioeconomic differences condition health care. J Hum Hypertens. 2001; 15(10): 727–731, doi: 10.1038/sj.jhh.1001249, indexed in Pubmed: 11607804.
  35. Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021; 78(5): 1197–1205, doi: 10.1161/HYPERTENSIONAHA.121.17981, indexed in Pubmed: 34601960.
  36. Asayama K, Sato A, Ohkubo T, et al. The association between masked hypertension and waist circumference as an obesity-related anthropometric index for metabolic syndrome: the Ohasama study. Hypertens Res. 2009; 32(6): 438–443, doi: 10.1038/hr.2009.37, indexed in Pubmed: 19390540.
  37. Ahn SK, Lee JM, Ji SMi, et al. Incidence Hypertension and Fasting Blood Glucose from Real-World Data: Retrospective Cohort for 7-Years Follow-Up. Int J Environ Res Public Health. 2021; 18(4), doi: 10.3390/ijerph18042085, indexed in Pubmed: 33669927.
  38. Kuwabara M, Chintaluru Y, Kanbay M, et al. Fasting blood glucose is predictive of hypertension in a general Japanese population. J Hypertens. 2019; 37(1): 167–174, doi: 10.1097/HJH.0000000000001895, indexed in Pubmed: 30507865.
  39. Lv Y, Yao Y, Ye J, et al. Association of Blood Pressure with Fasting Blood Glucose Levels in Northeast China: A Cross-Sectional Study. Sci Rep. 2018; 8(1): 7917, doi: 10.1038/s41598-018-26323-6, indexed in Pubmed: 29784970.
  40. Horikawa T, Obara T, Ohkubo T, et al. J-HOME Study Group. Difference between home and office blood pressures among treated hypertensive patients from the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res. 2008; 31(6): 1115–1123, doi: 10.1291/hypres.31.1115, indexed in Pubmed: 18716359.
  41. Kadowaki S, Kadowaki T, Hozawa A, et al. SESSA Research Group. Differences between home blood pressure and strictly measured office blood pressure and their determinants in Japanese men. Hypertens Res. 2021; 44(1): 80–87, doi: 10.1038/s41440-020-00533-w, indexed in Pubmed: 32863384.
  42. Rahmawati R, Bajorek B. Factors affecting self-reported medication adherence and hypertension knowledge: A cross-sectional study in rural villages, Yogyakarta Province, Indonesia. Chronic Illn. 2018; 14(3): 212–227, doi: 10.1177/1742395317739092, indexed in Pubmed: 29119817.
  43. Astutik E, Farapti F, Tama TD, et al. Differences risk factors for hypertension among elderly woman in rural and urban Indonesia. Yale J Biol Med. 2021; 94(3): 407–415, indexed in Pubmed: 34602880.
  44. Widyaningsih V, Febrinasari RP, Pamungkasari EP, et al. Scaling Up Non-Communicable Disease Intervention in South East Asia (SUNISEA) Project. Missed opportunities in hypertension risk factors screening in Indonesia: a mixed-methods evaluation of integrated health post (POSBINDU) implementation. BMJ Open. 2022; 12(2): e051315, doi: 10.1136/bmjopen-2021-051315, indexed in Pubmed: 35190419.
  45. Stergiou GS, Alpert B, Mieke S, et al. A Universal Standard for the Validation of Blood Pressure Measuring Devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. Hypertension. 2018; 71(3): 368–374, doi: 10.1161/HYPERTENSIONAHA.117.10237, indexed in Pubmed: 29386350.